Search
Pirinidazole
go.drugbank.com/drugs/DB21413ExperimentalThe usage of the INN stem '-nidazole' in the name indicates that Pirinidazole is a antiprotozoal and radiosensitizer, metronidazole derivative.
Canocapavir
go.drugbank.com/drugs/DB21570ExperimentalThe usage of the INN stem '-capavir' in the name indicates that Canocapavir is a viral capsid and nucleocapsid inhibitor. Canocapavir has a monoisotopic molecular weight of 561.08 Da.
KER-047
go.drugbank.com/drugs/DB19111InvestigationalKER-047 is under investigation in clinical trial NCT05927012 (A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (
Capeserod
go.drugbank.com/drugs/DB20267ExperimentalThe usage of the INN stem '-serod' in the name indicates that Capeserod is a serotonin receptor antagonist and partial agonist. Capeserod has a monoisotopic molecular weight of 456.16 Da.
Vibozilimod
go.drugbank.com/drugs/DB21505ExperimentalThe usage of the INN stem '-imod' in the name indicates that Vibozilimod is a immunomodulator, both stimulant/suppressive and stimulant. Vibozilimod has a monoisotopic molecular weight of 541.23 Da.
Zectivimod
go.drugbank.com/drugs/DB21525ExperimentalThe usage of the INN stem '-imod' in the name indicates that Zectivimod is a immunomodulator, both stimulant/suppressive and stimulant. Zectivimod has a monoisotopic molecular weight of 527.17 Da.
Icanbelimod
go.drugbank.com/drugs/DB21572ExperimentalThe usage of the INN stem '-imod' in the name indicates that Icanbelimod is a immunomodulator, both stimulant/suppressive and stimulant. Icanbelimod has a monoisotopic molecular weight of 409.18 Da.
Cerium oxalate
go.drugbank.com/drugs/DB13519ExperimentalCategories: Antiemetics and Antinauseants, Alimentary Tract and MetabolismPolicresulen
go.drugbank.com/drugs/DB13492InvestigationalCategories: Phenol and Derivatives, Antiseptics and DisinfectantsBMS-986104
go.drugbank.com/drugs/DB15214InvestigationalBMS-986104 is under investigation in clinical trial NCT02211469 (A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics